These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. Brown DM; Kaiser PK; Michels M; Soubrane G; Heier JS; Kim RY; Sy JP; Schneider S; N Engl J Med; 2006 Oct; 355(14):1432-44. PubMed ID: 17021319 [TBL] [Abstract][Full Text] [Related]
27. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis. Campbell RJ; Bell CM; Paterson JM; Bronskill SE; Moineddin R; Whitehead M; Gill SS Ophthalmology; 2012 Aug; 119(8):1604-8. PubMed ID: 22717458 [TBL] [Abstract][Full Text] [Related]
28. Innovative treatments for exudative age-related macular degeneration. Kim RW; Heier JS Int Ophthalmol Clin; 2004; 44(4):41-50. PubMed ID: 15577563 [No Abstract] [Full Text] [Related]
29. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment. Busch T Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798 [TBL] [Abstract][Full Text] [Related]
30. Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration. Calvo-González C; Reche-Frutos J; Donate-López J; García-Feijoó J; Leila M; Fernández-Pérez C; Garcia-Sánchez J Br J Ophthalmol; 2008 Jan; 92(1):74-5. PubMed ID: 18156376 [TBL] [Abstract][Full Text] [Related]
31. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834 [TBL] [Abstract][Full Text] [Related]
32. [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]. Klin Monbl Augenheilkd; 2007 Jul; 224(7):559-66. PubMed ID: 17657689 [TBL] [Abstract][Full Text] [Related]
33. Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration. McKibbin M; Papastefanou V; Matthews B; Cook H; Downey L Eye (Lond); 2010 Jun; 24(6):994-8. PubMed ID: 19911016 [TBL] [Abstract][Full Text] [Related]
34. Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration. Sweeney K Drug Discov Today; 2005 Oct; 10(20):1346-8. PubMed ID: 16253870 [No Abstract] [Full Text] [Related]